Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 22.13 | 12.44 |
PEG Ratio (TTM) | 4.01 | 4.23 |
P/S Ratio (TTM) | 1.81 | 1.38 |
P/B Ratio (TTM) | 4.77 | -10.78 |
P/FCF Ratio (TTM) | 36.46 | 18.24 |
Price to 5YR AVG Earnings Ratio | 27.57 | 19.29 |
Price to 5YR AVG FCF Ratio | 43.59 | 23.57 |
Profitability (60%) |
Company | Industry |
---|---|---|
ROA (TTM) | 6.54% | 5.28% |
ROE (TTM) | 23.50% | -83.47% |
Net Profit Margin (TTM) | 8.10% | 1.94% |
ROIC 5YR AVG | 15.08% | 16.73% |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 6.52% | 15.10% | 8.20% |
Revenue | 2.89% | 6.26% | 2.82% |
Net Income | 6.84% | 15.66% | 8.52% |
Cash Flow | 6.61% | -1.39% | 3.00% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.04 | 1.35 |
Quick Ratio (TTM) | 1.04 | 1.24 |
D/E Ratio (TTM) | 1.33 | -5.34 |
Interest Coverage (TTM) | 5.90 | 5.93 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 2.84 | 2.90 |
LTL to 5YR AVG FCF | 13.20 | 7.86 |
Shares Outstanding Growth 5YR AVG | 0.33% | -0.29% |